BOSOX
Price
$18.75
Change
-$0.17 (-0.90%)
Updated
Sep 20 closing price
VSMAX
Price
$113.90
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

BOSOX vs VSMAX

Header iconBOSOX vs VSMAX Comparison
Open Charts BOSOX vs VSMAXBanner chart's image
Boston Trust Walden Small Cap
Price$18.75
Change-$0.17 (-0.90%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Index Adm
Price$113.90
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
BOSOX vs VSMAX Comparison Chart
Loading...
VS
BOSOX vs. VSMAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOSOX is a Buy and VSMAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 149B vs. BOSOX (1.42B). VSMAX pays higher dividends than BOSOX: VSMAX (1.42) vs BOSOX (0.44). BOSOX was incepted earlier than VSMAX: BOSOX (19 years) vs VSMAX (24 years). BOSOX is a more actively managed with annual turnover of: 23.98 vs. VSMAX (12.00). VSMAX has a lower initial minimum investment than BOSOX: VSMAX (3000) vs BOSOX (100000). VSMAX annual gain was more profitable for investors over the last year : 20.75 vs. BOSOX (17.94). VSMAX return over 5 years is better than : 51.83 vs. BOSOX (29.03).
BOSOXVSMAXBOSOX / VSMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years24 years-
Gain YTD9.7709.731100%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets1.42B149B1%
Annual Yield % from dividends0.441.4231%
Returns for 1 year17.9420.7586%
Returns for 3 years2.915.7051%
Returns for 5 years29.0351.8356%
Returns for 10 years28.90114.0925%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CSGP76.851.12
+1.48%
CoStar Group
HLNE158.621.25
+0.79%
Hamilton Lane
MXL14.09-0.13
-0.91%
MaxLinear
PPTA8.57-0.32
-3.55%
Perpetua Resources Corp
LUMO3.70-0.18
-4.64%
Lumos Pharma